Showing 3491-3500 of 5689 results for "".
- AptarGroup Highlights New “Beat the Blink” Technologyhttps://modernod.com/news/aptargroup-highlights-new-beat-the-blink-technology/2485307/AptarGroup shared an overview of its portfolio of eye care solutions, including 'Beat the Blink,' a new eye care delivery system designed to improve dosing accuracy and enhance the patient experience by “beating the blink” reflex. The technology is currently part of
- Vision Expo 2026 Marks 40 Years With Expanded Education Experiencehttps://modernod.com/news/vision-expo-2026-marks-40-years-with-expanded-education-experience/2485286/Produced by RX and The Vision Council, Vision Expo is celebrating its 40th year in 2026 with an enhanced educational conference designed to deliver greater access, flexibility and real-world learning for vision care professionals.
- New International Myopia Guidance Urges Early, Personalized Carehttps://modernod.com/news/new-international-myopia-guidance-urges-early-personalized-care/2485288/The International Myopia Institute (IMI) has published its 2025 Digest, delivering the latest evidence-based guidance on myopia. The Dige
- 4DMT and Otsuka Announce Strategic Partnership to Advance 4D-150 Gene Therapy Across Asia-Pacifichttps://modernod.com/news/4dmt-and-otsuka-announce-strategic-partnership-to-advance-4d-150-gene-therapy-across-asia-pacific/2484301/4D Molecular Therapeutics (4DMT) announced a strategic partnership with Otsuka Pharmaceutical to develop and commercialize 4D-150 for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME) across the greater Asia-Pacific (
- Eli Lilly Enters Ophthalmology Sector with Acquisition of Adverum Biotechnologieshttps://modernod.com/news/eli-lilly-enters-ophthalmology-sector-with-acquisition-of-adverum-biotechnologies/2484212/Eli Lilly and Company and Adverum Biotechnologies announced that they have entered into a definitive agreement for Lilly to acquire Adverum Biotechnologies, including its lead gene therapy product candidate, Ixo-vec. I
- FDA Issues CRL to Sydnexis for SYD-101 in Pediatric Myopiahttps://modernod.com/news/fda-does-not-approve-sydnexis-syd-101-in-pediatric-myopia/2484210/The FDA has issued a complete response letter (CRL) for Sydnexis' new drug application (NDA) for SYD-101, a proprietary 0.01% atropine formulation designed to slow the progression of myopia in children. T
- OneSight EssilorLuxottica Foundation and Vision To Learn Extend Partnership to Expand Vision Care for Children Nationwidehttps://modernod.com/news/onesight-essilorluxottica-foundation-and-vision-to-learn-extend-partnership-to-expand-vision-care-for-children-nationwide/2484209/The OneSight EssilorLuxottica Foundation and Vision To Learn announced a 2-year extension of their 8-year partnership dedicated to providing vision care services to children in need—helping them see clearly and reach their full potential in school and be
- IDOC Unveils New Brand Identity and Platform for Optometristshttps://modernod.com/news/idoc-unveils-new-brand-identity-and-platform-for-optometrists/2484208/IDOC announced the launch of a refreshed brand identity and messaging platform designed to better serve independent optometrists. According to a news release, the revitalized brand aims to make independent ow
- Topcon Healthcare Launches IDHea to Advance Digital Research in Eye Care and Oculomicshttps://modernod.com/news/topcon-healthcare-launches-idhea-to-advance-digital-research-in-eye-care-and-oculomics/2484202/Topcon Healthcare announced the launch of IDHea Inc., the Institute for Digital Health, a new company dedicated to transforming clinical research in eye care and the emerging field of oculomics—the study of ocular biomarkers that reflect systemic health.
- AAO: Office-Based Cataract Surgery Study Shows Success With Minimal Oral Sedationhttps://modernod.com/news/aao-office-based-cataract-surgery-study-shows-success-with-minimal-oral-sedation/2484197/A new study presented at the 129th annual meeting of the American Academy of Ophthalmology (AAO) is challenging long-held assumptions about cataract surgery. The research demonstrates that patients can safely and successfully undergo office-based cataract surgery u